Atrys Health, S.A. (BME:ATRY)
2.810
-0.120 (-4.10%)
Sep 16, 2026, 5:35 PM CET
Atrys Health Market Cap
Atrys Health has a market cap or net worth of €222.41 million as of September 16, 2026. Its market cap has increased by 3.88% in one year.
Market Cap
222.41M
Enterprise Value
328.05M
Revenue
147.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.81
ChartMarket Cap Chart
Since July 22, 2016, Atrys Health's market cap has increased from 17.85M to 222.41M, an increase of 1,146.32%. That is a compound annual growth rate of 28.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 222.41M | 0.04% |
| Dec 31, 2025 | 222.31M | -13.13% |
| Dec 31, 2024 | 255.91M | -8.07% |
| Dec 29, 2023 | 278.37M | -39.03% |
| Dec 30, 2022 | 456.55M | -26.48% |
| Dec 30, 2021 | 620.95M | 107.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.86B |
| Laboratorios Farmaceuticos Rovi | 2.93B |
| Almirall | 2.22B |
| Faes Farma | 1.39B |
| Clínica Baviera | 913.89M |
| Oryzon Genomics | 228.51M |
| Prim, S.A. | 217.71M |
| Laboratorio Reig Jofre | 215.74M |